Skip to content
340B legislation advances in U.S. House
Key legislation providing greater transparency and oversight into the 340B federal drug program moved forward in the U.S. House on May 25. The House […]
340B legislation advances in U.S. House Read More »
Federal Policy
Are PBMs working in the interest of health care – or themselves?
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest
Are PBMs working in the interest of health care – or themselves? Read More »
Why Congress must repeal the R&D amortization provision
The Biotechnology Innovation Organization (BIO), along with its members, sent a letter to Congressional leadership earlier this month urging for legislative action to be
Why Congress must repeal the R&D amortization provision Read More »
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B
Pharmacy benefit managers (PBMs) and hospitals using the 340B program were in the crosshairs on May 17 as the House Energy & Commerce Health
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B Read More »
Who owns drugs developed with AI?
Inventions like AI-developed drugs belong to the human inventor, says the Biotechnology Innovation Organization (BIO) in comments to the U.S. Patent and Trademark Office
Who owns drugs developed with AI? Read More »
Senate HELP Committee advances PBM reform
U.S. Senators have been busy this week understanding and pushing forward PBM reform. On May 10, the Senate Health, Education, Labor, and Pensions (HELP) Committee
Senate HELP Committee advances PBM reform Read More »
What they said at the Senate HELP hearing on PAHPA reauthorization
“What scientists are telling us is that there is a reasonable chance that—God forbid—a pandemic is deadly as COVID-19 could occur in 10 years,”
What they said at the Senate HELP hearing on PAHPA reauthorization Read More »
Transformative therapies need new payment models, study finds
Exciting new therapies promise to transform medicine. But ensuring patients can access these complex treatments may require innovative payment models, says a study published
Transformative therapies need new payment models, study finds Read More »
Vote on Pharmacy Benefit Manager Reform Act delayed until May 11
The Senate Health, Education, Labor, and Pension (HELP) Committee on May 2 discussed Senate Bill 1339, “The Pharmacy Benefit Manager Reform Act,” and three
Vote on Pharmacy Benefit Manager Reform Act delayed until May 11 Read More »
Hearing on public health threat from AMR puts spotlight on PASTEUR Act
Ordinary market mechanisms are inadequate against the emerging public health threat of antimicrobial resistance (AMR), lawmakers and experts agreed at the April 28 hearing
Hearing on public health threat from AMR puts spotlight on PASTEUR Act Read More »